CHRISTOPHER CHANG: Open Payments
NPI 1457090110 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 9 payments from 7 companies in 2025. Trend: 2023 $1,286 · 2024 $1,635 · 2025 $168
Food & beverage: $166Education: $2
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| AKEBIA THERAPEUTICS INC | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $17 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: Fabhalta, JYNARQUE, Vafseo, Veltassa, LUPKYNIS, TARPEYO, Filspari.
Industry payments across GA — which companies pay providers there.
